Fundraising FoxPillar Biosciences
Natick, US · Delaware corporation · 4 known investors
Find your way into Pillar Biosciences
Sign up to see every warm intro you have to Pillar Biosciences
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Pillar Biosciences team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Pillar Biosciences develops kitted next-generation sequencing (NGS) panels and its SLIMamp single-tube library preparation technology for clinical and research laboratories, focused on cancer diagnostics. Its oncoReveal portfolio of RUO and IVD oncology panels covers solid tumors, hematologic cancers, and liquid biopsy, aiming to deliver faster, lower-cost genomic testing for precision medicine.
Founders & leadership
Board
Investors · 4
How we know: Catalio Capital Management, LP's portfolio page · Not right? Tell us
How we know: HB Ventures's portfolio page · Not right? Tell us
How we know: a partner's Signal profile · Not right? Tell us
How we know: funding news · press coverage · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$38M disclosed across 2 rounds · 2020–2021
▶$20MraisedJun 2021 · 1 investors · OtherRule 506(b)
- Shawn LiuDirector
- Hui YangDirector
- Gang SongExecutive Officer, Director
- Zhaohui WangDirector
- Robert ForresterDirector
- Hong Fang SongDirector
- Eric LaiDirector
- Offering amount
- $50.6M
- Amount sold
- $20M
- First sale
- May 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$18MraisedMar 2020 · 10 investors · BiotechnologyRule 506(b)
- Hong Fang SangDirector
- Shawn LiuDirector
- Hui YangDirector
- Gang SongExecutive Officer, Director
- Zhaohui WangDirector
- Offering amount
- $32.4M
- Amount sold
- $18M
- First sale
- Feb 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 3
Companies working in the same space as Pillar Biosciences.
In the news
Frequently asked questions
- What does Pillar Biosciences do?
- Pillar Biosciences develops kitted next-generation sequencing (NGS) panels and its SLIMamp single-tube library preparation technology for clinical and research laboratories, focused on cancer diagnostics. Its oncoReveal portfolio of RUO and IVD oncology panels covers solid tumors, hematologic cancers, and liquid biopsy, aiming to deliver faster, lower-cost genomic testing for precision medicine.
- Who are Pillar Biosciences's investors?
- Pillar Biosciences's investors include Catalio Capital Management, LP, HB Ventures, Bain Capital Life Sciences, Soleus Capital.
- How much funding has Pillar Biosciences raised?
- Pillar Biosciences has disclosed $38M raised across 2 rounds.
- Where is Pillar Biosciences headquartered?
- Pillar Biosciences is headquartered in Natick, US.